When: Q3 2026 earnings: margin fails to expand and consensus revises lower

Then: Convert trim to more meaningful reduction; puts pay out

Trim exposure 30-50%, tighten stops to 200 SMA at 1051, reject SKF overlay and pair trade, hold remaining position until regime change confirmed

• Stop at 1180 is only ~25 points (~1 ATR) from entry on a 1.43 beta name vulnerable to overnight gaps on macro events
• SKF overlay, pair trade (long IVZ/BEN vs short BLK), and Dec 2026 1000 puts create full short book with basis risk, liquidity risk, and gap risk that correlate during selloffs
• Aggressive analyst incorrectly extrapolates Q2's 13% decline from a record Q1 as a new lower trajectory rather than normalization
• Q2 2026 revenue of $7.08B represents 30% YoY growth versus $5.42B in Q2 2025
• Long-term technical regime intact: price 7.3% above 200 SMA, 50 SMA above 200 SMA (golden cross), 200 SMA at 1051 is the true regime-change line
• Near-term technical supports caution (MACD bearish crossover, RSI rollover, below 10 EMA) but most likely scenario is choppy 1117-1175 range, not breakdown
• BLK's 1.98% dividend yield reflects stability of never-cut dividends grown for over a decade versus peers that have cut
• BLK returns $5.3B annually, representing 2.9% of enterprise value as a mechanical bid under the stock
• Dec 2026 1000 strike puts price in ~13% decline over 15 months; bleeding premium if thesis is wrong plus getting stopped out at 1180 leaves BLK ripping to 1250 on positive Q3
• Conservative position: take profit, protect rest, avoid manufacturing risk the data does not require

→ vs aggressive: Reward-to-risk ratio is not asymmetric: stop at 1180 is only one ATR away on a 1.43 beta name, vulnerable to single overnight gap on CPI/Fed/macro data

→ vs aggressive: Forward P/E projection of 22-24x is projection disguised as analysis: Q1 was a record that naturally normalizes to Q2; extrapolating peak-to-pullback as new run rate ignores cyclical earnings patterns

→ vs aggressive: Macro short thesis lacks trigger: 89% odds of no cuts means no recession, which means earnings don't collapse; shorting second derivative without the first

→ vs aggressive: Capital return 'soft floor' argument misses that 1.98% yield on never-cut growing dividends is worth more than 4% yield on firms that have cut dividends recently

→ vs aggressive: Convexity argument is concentrated directional exposure: if macro is less dire than forecast, all legs bleed simultaneously with no offsetting hedge

→ vs aggressive: 200 SMA at 1051 is the line between normal pullback and regime change, not just a target; aggressive analyst assumes breakdown through 1117, 1082, and 1051 all at once before any support kicks in

Trim 30-40% of existing BLK exposure, keep remainder with stop at 1082-1090 (50 SMA), hedge with single instrument (Dec 2026 $1,000 puts or SKF), size for choppy range between 1117 and 1175 with slight downside bias

• Q1 2026 was a record quarter with $14.06 EPS, the highest in the dataset
• Revenue accelerated 30% YoY: from $5.42B in Q2 2025 to $7.08B in Q2 2026
• BUIDL at $2.8B in tokenized Treasuries represents leadership position in market projected to scale into trillions
• IBIT at $924M weekly inflows with sticky retail flows of annuity-like characteristics
• Technical base case: choppy range between 1117 and 1175 with slight downside bias
• Beta at 1.43 indicates meaningful drawdown exposure in bear markets
• Asset managers with best franchises still draw down 25-40% in real bear markets due to mechanical AUM beta
• Aggressive analyst target of $1,050-$1,080 requires technical breakdown to play out exactly without mean reversion
• Conservative analyst's 200 SMA stop at 1051 absorbs full 7% drawdown before any action
• GIP acquisition lift inflates revenue growth; organic growth once comps normalize is the relevant question

→ vs aggressive: Treating sequential Q1-to-Q2 EPS decline as deterioration is pattern-matching on single data point; Q1 was a record quarter, and cyclical earnings naturally reset after performance fee crystallization. Revenue accelerating 30% YoY contradicts franchise deterioration thesis. BUIDL at $2.8B is leadership in a category projected to scale into trillions with high-margin recurring fees. IBIT inflows represent sticky retail flows with annuity-like characteristics, not weakness. Target of $1,050-$1,080 requires technical breakdown to play out without mean reversion, against the base case range of 1117-1175.

→ vs conservative: Premium multiple and dividend growth don't immunize asset managers from bear market drawdowns; best franchises still fall 25-40% when AUM is mechanically tied to market beta. 200 SMA stop at 1051 absorbs full 7% drawdown before action, which is delayed capitulation, not conservatism. Acknowledges MACD bearish crossover, RSI rollover, price below 10 EMA, Bollinger midline, and VWAP simultaneously then shrugs it off—exactly the setup that precedes meaningful moves when macro catalyst hits. 30% YoY revenue growth includes GIP acquisition lift; organic growth once comps normalize is the relevant question.